203 related articles for article (PubMed ID: 25862759)
1. Brain Penetration and Efficacy of Different Mebendazole Polymorphs in a Mouse Brain Tumor Model.
Bai RY; Staedtke V; Wanjiku T; Rudek MA; Joshi A; Gallia GL; Riggins GJ
Clin Cancer Res; 2015 Aug; 21(15):3462-3470. PubMed ID: 25862759
[TBL] [Abstract][Full Text] [Related]
2. Quality evaluation of generic drugs by dissolution test: changing the USP dissolution medium to distinguish between active and non-active mebendazole polymorphs.
Swanepoel E; Liebenberg W; de Villiers MM
Eur J Pharm Biopharm; 2003 May; 55(3):345-9. PubMed ID: 12754010
[TBL] [Abstract][Full Text] [Related]
3. Preparation and Evaluation of Mebendazole Microemulsion for Intranasal Delivery: an Alternative Approach for Glioblastoma Treatment.
Mena-Hernández J; Jung-Cook H; Llaguno-Munive M; García-López P; Ganem-Rondero A; López-Ramírez S; Barragán-Aroche F; Rivera-Huerta M; Mayet-Cruz L
AAPS PharmSciTech; 2020 Sep; 21(7):264. PubMed ID: 32980937
[TBL] [Abstract][Full Text] [Related]
4. Identification of the mebendazole polymorphic form present in raw materials and tablets available in South Africa.
Liebenberg W; Dekker TG; Lötter AP; de Villiers MM
Drug Dev Ind Pharm; 1998 May; 24(5):485-8. PubMed ID: 9876612
[TBL] [Abstract][Full Text] [Related]
5. Repurposing Mebendazole as a Replacement for Vincristine for the Treatment of Brain Tumors.
De Witt M; Gamble A; Hanson D; Markowitz D; Powell C; Al Dimassi S; Atlas M; Boockvar J; Ruggieri R; Symons M
Mol Med; 2017 Apr; 23():50-56. PubMed ID: 28386621
[TBL] [Abstract][Full Text] [Related]
6. An alternative mebendazole formulation for cystic echinococcosis: the treatment efficacy, pharmacokinetics and safety in mice.
Liu CS; Zhang HB; Lei W; Zhang CW; Jiang B; Zheng Q; Yin JH; Han XM
Parasit Vectors; 2014 Dec; 7():589. PubMed ID: 25491386
[TBL] [Abstract][Full Text] [Related]
7. Quantitative analysis of mebendazole polymorphs in pharmaceutical raw materials using near-infrared spectroscopy.
da Silva VH; Gonçalves JL; Vasconcelos FV; Pimentel MF; Pereira CF
J Pharm Biomed Anal; 2015 Nov; 115():587-93. PubMed ID: 26320077
[TBL] [Abstract][Full Text] [Related]
8. Effective treatment of diverse medulloblastoma models with mebendazole and its impact on tumor angiogenesis.
Bai RY; Staedtke V; Rudin CM; Bunz F; Riggins GJ
Neuro Oncol; 2015 Apr; 17(4):545-54. PubMed ID: 25253417
[TBL] [Abstract][Full Text] [Related]
9. Comparison of macro and micro Raman measurement for reliable quantitative analysis of pharmaceutical polymorphs.
Paiva EM; da Silva VH; Poppi RJ; Pereira CF; Rohwedder JJR
J Pharm Biomed Anal; 2018 Aug; 157():107-115. PubMed ID: 29787964
[TBL] [Abstract][Full Text] [Related]
10. Mebendazole mesylate monohydrate: a new route to improve the solubility of mebendazole polymorphs.
de Paula K; Camí GE; Brusau EV; Narda GE; Ellena J
J Pharm Sci; 2013 Oct; 102(10):3528-38. PubMed ID: 23897162
[TBL] [Abstract][Full Text] [Related]
11. Portable near-infrared instruments: Application for quality control of polymorphs in pharmaceutical raw materials and calibration transfer.
da Silva VH; da Silva JJ; Pereira CF
J Pharm Biomed Anal; 2017 Feb; 134():287-294. PubMed ID: 27951470
[TBL] [Abstract][Full Text] [Related]
12. Plasma disposition, milk excretion and parasitological efficacy of mebendazole in donkeys naturally infected by Cyathostominae.
Gokbulut C; Aksit D; Santoro M; Roncoroni C; Mariani U; Buono F; Rufrano D; Fagiolo A; Veneziano V
Vet Parasitol; 2016 Feb; 217():95-100. PubMed ID: 26827868
[TBL] [Abstract][Full Text] [Related]
13. Inclusion complexes of β-cyclodextrin and polymorphs of mebendazole: Physicochemical characterization.
Saidman E; Chattah AK; Aragón L; Sancho M; Camí G; Garnero C; Longhi M
Eur J Pharm Sci; 2019 Jan; 127():330-338. PubMed ID: 30445224
[TBL] [Abstract][Full Text] [Related]
14. Antiparasitic mebendazole shows survival benefit in 2 preclinical models of glioblastoma multiforme.
Bai RY; Staedtke V; Aprhys CM; Gallia GL; Riggins GJ
Neuro Oncol; 2011 Sep; 13(9):974-82. PubMed ID: 21764822
[TBL] [Abstract][Full Text] [Related]
15. Characterization of polymorph transformations that decrease the stability of tablets containing the WHO essential drug mebendazole.
Brits M; Liebenberg W; de Villiers MM
J Pharm Sci; 2010 Mar; 99(3):1138-51. PubMed ID: 19691117
[TBL] [Abstract][Full Text] [Related]
16. Mebendazole crystal forms in tablet formulations. An ATR-FTIR/chemometrics approach to polymorph assignment.
Calvo NL; Kaufman TS; Maggio RM
J Pharm Biomed Anal; 2016 Apr; 122():157-65. PubMed ID: 26874854
[TBL] [Abstract][Full Text] [Related]
17. Emerging Perspectives on the Antiparasitic Mebendazole as a Repurposed Drug for the Treatment of Brain Cancers.
Meco D; Attinà G; Mastrangelo S; Navarra P; Ruggiero A
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674870
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and characterization of a new mebendazole salt: mebendazole hydrochloride.
Brusau EV; Camí GE; Narda GE; Cuffini S; Ayala AP; Ellena J
J Pharm Sci; 2008 Jan; 97(1):542-52. PubMed ID: 17854049
[TBL] [Abstract][Full Text] [Related]
19. Efficacy against subcutaneous or intracranial murine GL261 gliomas in relation to the concentration of the vascular-disrupting agent, 5,6-dimethylxanthenone-4-acetic acid (DMXAA), in the brain and plasma.
Yung R; Seyfoddin V; Guise C; Tijono S; McGregor A; Connor B; Ching LM
Cancer Chemother Pharmacol; 2014 Mar; 73(3):639-49. PubMed ID: 24477604
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of single-dose mebendazole, polymorphic forms A and C, in the treatment of hookworm and Trichuris infections.
Charoenlarp P; Waikagul J; Muennoo C; Srinophakun S; Kitayaporn D
Southeast Asian J Trop Med Public Health; 1993 Dec; 24(4):712-6. PubMed ID: 7939946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
